# FDA Inspection 1098170 - Lifeshare Blood Center - June 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/b7fad4dd-05c7-4027-a38f-65ba236af0c3
Source feed: FDA_Inspections

> FDA Inspection 1098170 for Lifeshare Blood Center on June 26, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098170
- Company Name: Lifeshare Blood Center
- Inspection Date: 2019-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253723 - 2024-10-30](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/921d6625-d976-44de-870e-cba64601029f)
- [FDA Inspection 1253723 - 2024-10-30](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/80672922-aa4c-49a9-89f7-fc485e97f5fa)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/a3448646-e0d1-4487-b9b9-b2286712ea37

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d